Results 1 to 10 of about 399,591 (306)
After Giulio Bizzozero identified platelets at the end of the 19th century,[1][1] many authors sought to define the normal concentration of these elements in human blood. However, methods to enumerate platelets remained inaccurate until the middle of the last century, and the proposed ...
Carlo L. Balduini, Patrizia Noris
doaj +4 more sources
Monocarboxyoctyl phthalate is associated with platelet count: evidence from a large cross-sectional study [PDF]
IntroductionPhthalates are environmental pollutants that are harmful to human health. However, the impact of phthalate on platelet count remains unclear. This study aimed to examine the correlation between five phthalate metabolites in urine and platelet
Jian Zhang +3 more
doaj +2 more sources
Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag
Background & Aims: Despite limitations, platelet transfusion has been used to minimise bleeding risk in patients with thrombocytopaenia. Lusutrombopag is an oral, thrombopoietin receptor agonist approved for treatment of thrombocytopaenia associated ...
Robert S. Brown, Jr. +7 more
doaj +1 more source
Platelet Counts during Pregnancy [PDF]
(N Engl J Med. 2018;379:32–43) In the present study, the authors evaluated platelet counts in women (15 to 44 y of age) who delivered at the Oklahoma University Medical Center between 2011 and 2014. Their objectives were to (1) evaluate the potential severity of gestational thrombocytopenia (<150,000 platelets/mm3 at the time of delivery ...
Jessica A, Reese +7 more
openaire +5 more sources
Impedance aggregometry (Multiplate®) detects the effects of platelet aggregation inhibitors and can predict thrombotic complications after coronary and cerebrovascular stent interventions.
Mohamed Soliman, Matthias Hartmann
doaj +1 more source
Decreased platelet count in patients receiving continuous veno-venous hemofiltration: a single-center retrospective study. [PDF]
BACKGROUND: A decreased platelet count may occur and portend a worse outcome in patients receiving continuous renal replacement therapy (CRRT). We aim to investigate the incidence of decreased platelet count and related risk factors in patients receiving
Buyun Wu +5 more
doaj +1 more source
Recovery of Platelet Count among Apheresis Platelet Donors [PDF]
Introduction: Increase in awareness regarding use of single donor platelets and the availability of technology has resulted in increased platelet pheresis procedures.
Ravindra Prasad Thokala +3 more
doaj +1 more source
Objectives Platelet count is an independent predictor of mortality in patients with cancer. It remains unknown whether the platelet count is related to in-hospital mortality in severely ill patients with tumours.Design A retrospective study based on a ...
Yue Chen +12 more
doaj +1 more source
Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study. [PDF]
BACKGROUND: Elevated platelet count is associated with risk of venous thromboembolism in cancer patients initiating chemotherapy. It is not known whether this risk by platelet count is causal or merely reflects the malignant disease.
Hilde Jensvoll +3 more
doaj +1 more source
Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. [PDF]
This prospective observational study was designed to analyze platelet functions across time in 50 patients scheduled for liver transplantation (LT) secondary to decompensated cirrhosis or hepatocellular carcinoma.
Daniel Eyraud +15 more
doaj +1 more source

